carbazilquinone has been researched along with Cancer of Prostate in 2 studies
Carbazilquinone: An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ito, H | 2 |
Ikeda, K | 1 |
Niwa, N | 1 |
Oka, F | 1 |
Abe, H | 1 |
Nakagami, Y | 1 |
1 trial available for carbazilquinone and Cancer of Prostate
Article | Year |
---|---|
[Experimental study and clinical application of a new combination chemotherapy with cis-platinum, adriamycin and carboquone in patients with advanced prostate cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Cisplatin; | 1995 |
1 other study available for carbazilquinone and Cancer of Prostate
Article | Year |
---|---|
[A case of advanced prostatic cancer presenting as inguinal mass].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Cisplatin; Di | 1991 |